Insulin resistance and vitamin D deficiency in patients with chronic kidney disease stage 2-3

Physiological Research

Volumn 60, Issue 1, 2011, Pages 149-155

  Stefikova K ^a   Spustova V ^a   Krivosikova Z ^a   Oksa A ^a   Gazdikova K ^a   Fedelesova V ^a   Dzurik R ^a  

^a SLOVAK MEDICAL UNIVERSITY   (Slovakia)

Author keywords

1,25(OH)2 vitamin D; 25(OH) vitamin D; Chronic kidney disease; Insulin resistance; Proteinuria

Indexed keywords

EID: 79955811762     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: 10.33549/physiolres.931814     Document Type: Article

References (25)

1. BOUCHER BJ, MANNAN N, NOOMAN K, HALES CN, EVANS SJ: Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia 38: 1239-1245, 1995.
2. BOUCHER BJ: Inadequate vitamin D status: does it contribute to the disorders comprising syndrom "X"? Br J Nutr 79: 315-327, 1998.
3. CHEN J, MUNTNER P, HAMM LL, FONESCA V, BATUMAN V, WHELTON PK, HE J: Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 14: 469-477, 2003.
4. CHEN J, MUNTNER P, HAMM LL, JONES DW, BATUMAN V, FONESCA V, WHELTON PK, HE J: The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Int Med 140: 167-174, 2004.
5. CHIU KC, CHU A, GO VL, SAAD MF: Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79: 820-825, 2004.
6. CHONCHOL M, SCRAGG R: 25-hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int 71: 134-139, 2007.
7. DUSSO AS, BROWN AJ, SLATOPOLSKY E: Vitamin D. Am J Renal Physiol 289: F8-F28, 2005.
8. FLISER D, PACINI G, ENGELLEITER R, KAUTZKY-WILLER A, PRAGER R, FRANEK E, RITZ E: Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 53: 1343-1347, 1998.
9. FORD ES, GILES WH, DIETZ WH: Prevalence of the metabolic syndrome among US adults: findings form the third National Health and Nutrition Examination Survey. JAMA 287: 356-359, 2002.
10. FORD ES, AJANI UA, MCGUIRE LC, LIU S: Concentrations of serum vitamin D and the metabolic syndrome among US adults. Diabet Care 28: 1228-1230, 2005.
11. FOROUGHI NG, LUAN J, COOPER A, BOUCHER BJ, WAREHAM N: Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 57: 2619-2625, 2008.
12. GONZALES EA, SACHCEVA A, OLIVER DA, MARTIN KJ: Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 24: 503-510, 2004.
13. GRUNDY SM, BREWER HB Jr, CLEEMAN JI, SMITH SC Jr, LENFANT C; American Heart Association; National Heart, Lung, and Blood Institute: Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109: 433-438, 2004.
14. HOEHNER CM, GREENLUND KJ, RITH-NAJARIAN S, CASPER ML, MCCLELLAN WM: Association of the insulin resistance syndrome and microalbuminuria among nondiabeteic native Americans. The Inter-Tribal Heart Project. J Am Soc Nephrol 13: 1626-1634, 2002.
15. HOLICK MF: Sunlight and vitamin D for health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80 (6 suppl): 1678S-1688S, 2004.
16. HOLICK MF: Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79: 362-371, 2004. http://www.kidney.org/professionals/kdoqi/gfr_calculator.cfm
17. ISHIMURA E, NISHIZAWA Y, INABA M, MATSUMOTO N, EMOTO M, KAVAGISHI T, SHOJI S, OKUNO S, KIM M, MIKI T, MORII H: Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int 55: 1019-1027, 1999.
18. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (2 Suppl 1): S1-S266, 2002.
19. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42 (4 Suppl 3): S1-S201, 2003.
20. KATO Y, HAYASHI M, OHNO Y, SUZAWA T, SASAKI T, SARUTA T: Mild renal dysfunction is associated with insulin resistance in chronic glomerulonephritis. Clin Nephrol 54: 366-373, 2000.
21. KATZ A, NAMBI SS, MATHER K, BARON AD, FOLLMANN DA, SULLIVAN G, QUON MJ: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85: 2402-2410, 2000.
22. MEHROTRA R, KERMAH D, BUDOFF M, SALUSKY IB, MAO SS, GAO YL, TAKASU J, ADLER S, NORRIS K: Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol 3: 1144-1151, 2008.
23. OKŠA A, SPUSTOVÁ V, KRIVOŠÍKOVÁ Z, GAZDÍKOVÁ K, FEDELEŠOVÁ V, LAJDOVÁ I, ŠTEFÍKOVÁ K, BERNASOVSKÁ G, ŽILINSKÁ Z, DZÚRIK R: Effect of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones chronic kidney disease. Kidney Blood Press Res 31: 322-329, 2008.
24. REMUZZI A: Vitamin D, insulin resistance, and renal disease. Kidney Int 71: 96-98, 2007.
25. TUTTLE KR: Renal manifestations of the metabolic syndrome. Nephrol Dial Transplant 20: 861-864, 2005.